tiprankstipranks
Shanghai Pharmaceuticals Holding Co Ltd Class H (HK:2607)
:2607
Hong Kong Market
2607
Shanghai Pharmaceuticals Holding Co
RESEARCH TOOLSreports

Shanghai Pharmaceuticals Holding Co (2607) Ratios

5 Followers

Shanghai Pharmaceuticals Holding Co Ratios

HK:2607's free cash flow for Q4 2025 was ¥0.12. For the 2025 fiscal year, HK:2607's free cash flow was decreased by ¥ and operating cash flow was ¥0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.33 1.33 1.36 1.33 1.35
Quick Ratio
 1.00 1.00 1.05 1.03 1.04
Cash Ratio
 0.24 0.24 0.28 0.25 0.25
Solvency Ratio
 0.05 0.06 0.05 0.05 0.07
Operating Cash Flow Ratio
 0.05 0.05 0.05 0.04 0.04
Short-Term Operating Cash Flow Coverage
 0.14 0.14 0.15 0.15 0.17
Net Current Asset Value
¥ 37.10B¥ 37.10B¥ 34.36B¥ 30.79B¥ 29.38B
Leverage Ratios
Debt-to-Assets Ratio
 0.21 0.21 0.22 0.20 0.19
Debt-to-Equity Ratio
 0.65 0.65 0.67 0.63 0.58
Debt-to-Capital Ratio
 0.39 0.39 0.40 0.38 0.37
Long-Term Debt-to-Capital Ratio
 0.05 0.05 0.10 0.08 0.09
Financial Leverage Ratio
 3.07 3.07 3.09 3.09 2.95
Debt Service Coverage Ratio
 0.14 0.25 0.25 0.24 0.36
Interest Coverage Ratio
 5.88 5.90 5.01 4.61 5.34
Debt to Market Cap
 0.76 1.27 1.06 1.08 0.85
Interest Debt Per Share
 13.80 13.80 13.34 12.04 11.56
Net Debt to EBITDA
 1.84 1.17 1.00 1.14 0.90
Profitability Margins
Gross Profit Margin
10.73%10.73%11.13%11.88%13.14%
EBIT Margin
2.91%4.06%3.50%3.35%4.41%
EBITDA Margin
3.21%5.07%4.38%4.19%5.36%
Operating Profit Margin
3.49%3.51%2.96%2.95%3.89%
Pretax Profit Margin
3.46%3.46%2.91%2.71%3.80%
Net Profit Margin
2.02%2.02%1.65%1.45%2.42%
Continuous Operations Profit Margin
2.46%2.46%2.13%1.98%3.01%
Net Income Per EBT
58.30%58.30%56.76%53.41%63.77%
EBT Per EBIT
99.10%98.77%98.52%92.01%97.71%
Return on Assets (ROA)
2.46%2.46%2.06%1.78%2.84%
Return on Equity (ROE)
7.64%7.54%6.35%5.50%8.38%
Return on Capital Employed (ROCE)
10.12%10.15%8.55%8.56%10.31%
Return on Invested Capital (ROIC)
4.95%4.97%4.47%4.49%6.21%
Return on Tangible Assets
2.70%2.70%2.23%1.94%3.12%
Earnings Yield
9.03%15.10%10.37%9.84%14.07%
Efficiency Ratios
Receivables Turnover
 3.19 3.19 3.23 3.37 3.19
Payables Turnover
 4.12 4.12 4.11 4.20 3.91
Inventory Turnover
 5.58 5.58 6.28 6.26 5.85
Fixed Asset Turnover
 14.71 14.71 14.46 14.22 14.33
Asset Turnover
 1.22 1.22 1.24 1.23 1.17
Working Capital Turnover Ratio
 6.29 6.23 6.41 6.60 7.31
Cash Conversion Cycle
 91.39 91.39 82.50 79.54 83.50
Days of Sales Outstanding
 114.53 114.53 113.14 108.20 114.48
Days of Inventory Outstanding
 65.40 65.40 58.11 58.28 62.42
Days of Payables Outstanding
 88.53 88.53 88.76 86.94 93.41
Operating Cycle
 179.92 179.92 171.25 166.48 176.91
Cash Flow Ratios
Operating Cash Flow Per Share
 1.72 1.66 1.57 1.41 1.36
Free Cash Flow Per Share
 1.09 1.03 0.92 0.61 0.59
CapEx Per Share
 0.63 0.63 0.65 0.80 0.77
Free Cash Flow to Operating Cash Flow
 0.63 0.62 0.59 0.43 0.43
Dividend Paid and CapEx Coverage Ratio
 1.77 1.20 0.97 0.75 0.82
Capital Expenditure Coverage Ratio
 2.75 2.65 2.43 1.76 1.77
Operating Cash Flow Coverage Ratio
 0.13 0.12 0.12 0.12 0.12
Operating Cash Flow to Sales Ratio
 0.02 0.02 0.02 0.02 0.02
Free Cash Flow Yield
6.35%10.10%7.80%5.90%5.16%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 11.07 6.62 9.65 10.16 7.11
Price-to-Sales (P/S) Ratio
 0.22 0.13 0.16 0.15 0.17
Price-to-Book (P/B) Ratio
 0.84 0.50 0.61 0.56 0.60
Price-to-Free Cash Flow (P/FCF) Ratio
 15.74 9.90 12.82 16.94 19.39
Price-to-Operating Cash Flow Ratio
 9.92 6.16 7.54 7.32 8.42
Price-to-Earnings Growth (PEG) Ratio
 5.61 0.26 0.47 -0.28 -0.71
Price-to-Fair Value
 0.84 0.50 0.61 0.56 0.60
Enterprise Value Multiple
 8.81 3.80 4.64 4.65 4.11
Enterprise Value
 80.13B 54.66B 55.96B 50.68B 51.08B
EV to EBITDA
 8.81 3.80 4.64 4.65 4.11
EV to Sales
 0.28 0.19 0.20 0.19 0.22
EV to Free Cash Flow
 19.90 14.28 16.33 22.42 24.81
EV to Operating Cash Flow
 12.54 8.88 9.60 9.69 10.77
Tangible Book Value Per Share
 18.41 18.41 18.02 16.91 17.25
Shareholders’ Equity Per Share
 20.46 20.46 19.35 18.51 19.26
Tax and Other Ratios
Effective Tax Rate
 0.29 0.29 0.27 0.27 0.21
Revenue Per Share
 76.47 76.47 74.30 70.33 66.61
Net Income Per Share
 1.54 1.54 1.23 1.02 1.61
Tax Burden
 0.58 0.58 0.57 0.53 0.64
Interest Burden
 1.19 0.85 0.83 0.81 0.86
Research & Development to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
 0.05 0.07 0.03 <0.01 <0.01
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 <0.01 <0.01
Income Quality
 9.29 0.88 0.99 1.01 0.68
Currency in CNY